Private Harbour Investment Management & Counsel’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Private Harbour Investment Management & Counsel’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,713	Closed	-$864K	–	61
2021 Q4	$864K	Sell	7,713 -424	-5%	-$51.1K	0.69%	46
2021 Q3	$1.02M	Sell	8,137 -10	-0.1%	-$1.29K	0.9%	39
2021 Q2	$1.1M	Sell	8,147 -340	-4%	-$44.7K	0.97%	39
2021 Q1	$1.15M	Sell	8,487 -110	-1%	-$16.5K	1.04%	42
2020 Q4	$1.21M	Sell	8,597 -75	-0.9%	-$9.61K	1.2%	37
2020 Q3	$966K	Sell	8,672 -90	-1%	-$10.1K	1.02%	40
2020 Q2	$981K	Sell	8,762 -65	-0.7%	-$6.4K	1.07%	40
2020 Q1	$684K	Sell	8,827 -177	-2%	-$15.7K	0.81%	45
2019 Q4	$856K	Sell	9,004 -434	-5%	-$37.5K	0.88%	43
2019 Q3	$720K	Hold	9,438	–	–	0.75%	47
2019 Q2	$828K	Buy	+9,438	New	+$805K	0.85%	47

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Private Harbour Investment Management & Counsel's XBI Position: Q1 2022 in Review

Private Harbour Investment Management & Counsel sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 7,713 shares — an estimated $864K sold.

Private Harbour Investment Management & Counsel first reported a position in XBI in Q2 2019 and held it in 11 quarters. The position peaked at $1.21M in Q4 2020. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

Private Harbour Investment Management & Counsel reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
Private Harbour Investment Management & Counsel sold 7,713 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $864K.
Private Harbour Investment Management & Counsel first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and held it in 11 quarters.
Private Harbour Investment Management & Counsel's State Street SPDR S&P Biotech ETF position peaked at $1.21M in Q4 2020.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on Private Harbour Investment Management & Counsel's 13F filing for Q1 2022, filed 10 May 2022.